Stack Financial Management Inc Has $8.08 Million Holdings in Zimmer Biomet Holdings, Inc. (ZBH)

Stack Financial Management Inc lessened its stake in Zimmer Biomet Holdings, Inc. (NYSE:ZBH) by 0.9% during the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 69,026 shares of the medical equipment provider’s stock after selling 645 shares during the period. Stack Financial Management Inc’s holdings in Zimmer Biomet Holdings were worth $8,082,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other institutional investors and hedge funds also recently bought and sold shares of ZBH. Wellington Management Group LLP grew its stake in Zimmer Biomet Holdings by 8.5% in the first quarter. Wellington Management Group LLP now owns 30,549 shares of the medical equipment provider’s stock valued at $3,731,000 after purchasing an additional 2,396 shares during the last quarter. Anchor Capital Advisors LLC grew its stake in shares of Zimmer Biomet Holdings by 0.5% during the first quarter. Anchor Capital Advisors LLC now owns 436,588 shares of the medical equipment provider’s stock worth $53,312,000 after acquiring an additional 2,135 shares during the last quarter. Segall Bryant & Hamill LLC grew its stake in shares of Zimmer Biomet Holdings by 42.2% during the first quarter. Segall Bryant & Hamill LLC now owns 9,270 shares of the medical equipment provider’s stock worth $1,132,000 after acquiring an additional 2,753 shares during the last quarter. Ngam Advisors L.P. grew its stake in shares of Zimmer Biomet Holdings by 10.8% during the first quarter. Ngam Advisors L.P. now owns 54,522 shares of the medical equipment provider’s stock worth $6,658,000 after acquiring an additional 5,315 shares during the last quarter. Finally, Financial Counselors Inc. grew its stake in shares of Zimmer Biomet Holdings by 46.2% during the first quarter. Financial Counselors Inc. now owns 6,142 shares of the medical equipment provider’s stock worth $750,000 after acquiring an additional 1,940 shares during the last quarter. Institutional investors own 85.26% of the company’s stock.

Shares of Zimmer Biomet Holdings, Inc. (NYSE ZBH) traded down 2.07% on Monday, reaching $121.88. The company’s stock had a trading volume of 519,563 shares. The company has a market capitalization of $24.64 billion, a price-to-earnings ratio of 34.71 and a beta of 1.19. The stock has a 50-day moving average price of $117.99 and a 200-day moving average price of $120.43. Zimmer Biomet Holdings, Inc. has a 1-year low of $95.63 and a 1-year high of $133.49.

Zimmer Biomet Holdings (NYSE:ZBH) last announced its earnings results on Thursday, July 27th. The medical equipment provider reported $2.08 earnings per share for the quarter, missing the consensus estimate of $2.10 by ($0.02). Zimmer Biomet Holdings had a net margin of 9.12% and a return on equity of 16.70%. The company had revenue of $1.95 billion during the quarter, compared to analysts’ expectations of $1.95 billion. During the same quarter last year, the business posted $2.02 earnings per share. The company’s revenue for the quarter was up 1.1% compared to the same quarter last year. On average, equities research analysts forecast that Zimmer Biomet Holdings, Inc. will post $8.23 EPS for the current year.

The business also recently announced a quarterly dividend, which was paid on Friday, October 27th. Shareholders of record on Friday, September 22nd were paid a $0.24 dividend. The ex-dividend date of this dividend was Thursday, September 21st. This represents a $0.96 annualized dividend and a dividend yield of 0.77%. Zimmer Biomet Holdings’s dividend payout ratio (DPR) is currently 27.59%.

WARNING: This article was originally reported by Community Financial News and is owned by of Community Financial News. If you are accessing this article on another publication, it was illegally copied and republished in violation of US & international copyright & trademark law. The original version of this article can be viewed at https://www.com-unik.info/2017/10/30/stack-financial-management-inc-has-8-08-million-holdings-in-zimmer-biomet-holdings-inc-zbh.html.

ZBH has been the topic of a number of research analyst reports. Zacks Investment Research lowered Zimmer Biomet Holdings from a “hold” rating to a “strong sell” rating in a research note on Tuesday, August 8th. Morgan Stanley boosted their price target on Zimmer Biomet Holdings from $137.00 to $150.00 and gave the stock an “overweight” rating in a research note on Monday, July 17th. Oppenheimer Holdings Inc. set a $137.00 price target on Zimmer Biomet Holdings and gave the stock a “buy” rating in a research note on Monday, August 14th. BMO Capital Markets restated a “buy” rating and set a $136.00 price target on shares of Zimmer Biomet Holdings in a research note on Tuesday, July 11th. Finally, Canaccord Genuity restated a “buy” rating and set a $141.00 price target on shares of Zimmer Biomet Holdings in a research note on Friday, July 14th. Three investment analysts have rated the stock with a sell rating, eight have issued a hold rating, thirteen have issued a buy rating and one has given a strong buy rating to the company. Zimmer Biomet Holdings presently has an average rating of “Hold” and a consensus price target of $136.55.

About Zimmer Biomet Holdings

Zimmer Biomet Holdings, Inc is engaged in designing, manufacturing and marketing of orthopedic reconstructive products; sports medicine, biologics, extremities and trauma products; office-based technologies; spine, craniomaxillofacial and thoracic products; dental implants, and related surgical products.

Institutional Ownership by Quarter for Zimmer Biomet Holdings (NYSE:ZBH)

What are top analysts saying about Zimmer Biomet Holdings Inc.? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for Zimmer Biomet Holdings Inc. and related companies.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit